|Last Price||Today's Change||52-Week Range||Trading Volume|
|61.44||0.93 (+1.54%)||47.55 - 70.54||9.5 million|
Market data as of 4:00PM 10/09/15. Quotes are delayed by at least 15 min.
Bristol-Myers Squibb’s Opdivo (nivolumab) Receives Expanded FDA Approval in Previously-Treated Metastatic Non-Small Cell Lung Cancer (NSCLC), Offering Improved Survival to More Patients
10/09/2015 3:02 PM ET